FDAFDA recall D-0871-2026 · Sep 30, 2026
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: Clear Eyes Redness Relief recall
Recall found
Product
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason for recall
Lack of Assurance of Sterility
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.
- Distribution
- Nationwide in the USA.
- Recalling firm
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-09-15
Source: openFDA enforcement record D-0871-2026 · search recall number D-0871-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 22, 2026, 4:56 AM EDT. The agency notice is the final word.